Avital M Miller

10PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersProbability theoryRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Applied statistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 25, 2026
Overall survival in oncology phase III trials: an individual patient level meta-analysis (OPTIMA).

|May 01, 2026
Interpreting Treatment Effects Using Posterior Probabilities: A Bayesian Reanalysis of 230 Phase III Oncology Trials.

|Feb 07, 2026
Control arm overperformance in phase 3 oncology clinical trials.

Ansel P Nalin, Pavlos Msaouel, Adam J Grippin

|Aug 29, 2025
Patient, Physician, and Assessor Blinding in Phase III Randomized Trials in Oncology: A Meta-Epidemiological Analysis.

Gabrielle Brown, Pavlos Msaouel, Avital M Miller

|Jan 27, 2025
Survival-Inferred Fragility of Statistical Significance in Phase III Oncology Trials.

Alexander D Sherry, Yufei Liu, Pavlos Msaouel

|Jan 08, 2025
Incomplete Toxicity Reporting and Use of Toxicity-Minimizing Language in Phase III Oncology Trials.

Avital M Miller, Adina H Passy, Alexander D Sherry

Pageof 2

Frequent Collaborators

10 joint publications

Alexander D Sherry

10 joint publications

Ethan B Ludmir

9 joint publications

Ramez Kouzy

9 joint publications

Pavlos Msaouel